|
IridoForce : solution against arthritis and rhuematism symptoms
Complex of Harpagosides, up to 20% by HPLC
IridoForceTM is not a simple extract. It's the solution making possible to adjust the assay in harpagosides in your galenic formulation... the high percentage of Harpagosides (up to 20% by HPLC, more than 40% by UV) enables you today to bring in the same capsule the gluco-iridoïdes, and other actives such as chondroïtine sulphate, or glucosamine, in order to obtain the best effectiveness. Irido-force exist in the specific title you need to bring the needed actives without increasing the daily number of catches. So : only one daily intake is needed to reach 40mg of Harpagosides. For example, Irido-forceTM 40 (20% of harpagoside by HPLC, 40 by UV) makes it possible to bring into 1 capsule of 200mg per day the contribution recommended in harpagosides (two capsules of 200mg would allow also other actives). This corresponds to nearly 8 capsules of devil's claw of the traditional extract of harpagophytum presently available (2% harpagosides, at a rate of min. 320 mg by capsule)!!! - Only one daily intake is needed
- Up to 20% Harpagoside by HPLC
- Scientific dossier available upon request
- Clinical studies on anti-inflammatory properties, regeneration of chondrocytes and anti-COX2
- Registration under European mutual recognication
- Produced under the strictest manufacturing procedures: ISO 22 000 (certified 01/19/2007)
Efficient (scientific results available) : Anti-inflammatory action Pain improvement Arhus index improvement Action on arthritis Action on law back pain Relevant: No adverse effects No toxicity Innovative: Reduction of daily intake Galenic innovation
Clinical works have linked Gluco-iridoids from Harpagophytum procumbens, and in particular Harpagoside, to the treatment of chronic and degenerative joint diseases. In addition, the high titration of IridoForceTM allows you to develop new innovative formulas. After its success to reach a targeted very high titration, Burgundy launched the study of activity of its IridoForce (complex of harpagosides) on the chondrocytes and the COX-2 in order to highlight the effects of the gluco-iridoïdes (and in particular the harpagoside) against the chronic inflammation of the cells which build the cartilage (chondrocytes), in charge for the progressive destruction. IridoForce is available from 3% to 20% harpagosides [HPLC], or 5% to 40% [UV].
Télécharger Burgundy - Brochure IridoForce.pdf
|